News
Sant Joan de Déu coordinates the European project AriChall to promote a new clinical trial in pediatric leukemia
Sant Joan de Déu coordinates the European project AriChall, an international initiative that promotes a new clinical trial with the aim of identifying a treatment for children with acute lymphoblastic leukemia (ALL) in first relapse through the CAR-T ARI-0001 therapy.
New study reveals that one in four patients who start treatment with benzodiazepines uses them for a long time
According to the data analyzed, 27.1% of patients who receive a new prescription for this type of drug end up becoming long-term users after three months, and 14.5% are still so after six months.
An intervention based on the Mediterranean diet during pregnancy positively modifies the mother’s gut microbiota
The IMPACT BCN study analyses how the Mediterranean diet and stress reduction during pregnancy influence the maternal gut microbiota.
Agenda
#ViernesCientíficos |Diabetes tipo 1 y salud emocional en la adolescencia: un reto invisible
Seminario a cargo de la Dra. Elisa Civitani Monzón. Enfermera experta en educación terapéutica en diabetes. Unidad de Diabetes Pediátrica. Hospital Universitario Miguel Servet. Zaragoza.
TECSAM | Dona i innovació: emprenedoria i inversió amb impacte
La Xarxa TECSAM, en col·laboració amb WA4STEAM, organitza una trobada adreçada a persones emprenedores de l'àmbit científic, tecnològic i de la salut interessades a conèixer com preparar projectes innovadors per créixer i accedir a finançament.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
